Many investigations undertaken with the aim of assessing a direct effect of PPARγ agonists on different processes involved in breast carcinogenesis demonstrated that these molecules induce cell growth inhibition, trigger cell death, inhibit breast cancer cell motility, and invasion. The gene discussed is PPARG; the disease is breast carcinoma.